Start Time: 16:30 January 1, 0000 4:27 PM ET
Bionano Genomics, Inc. (NASDAQ:BNGO)
Q1 2024 Earnings Conference Call
May 08, 2024, 16:30 PM ET
Company Participants
Erik Holmlin - President and CEO
Gülsen Kama - CFO
David Holmes - IR
Conference Call Participants
Sung Ji Nam - Scotiabank
Operator
Good day, and welcome to the Bionano First Quarter 2024 Earnings Conference Call. Today's conference is being recorded.
At this time, I would like to turn the conference over to David Holmes from Investor Relations. Please go ahead.
David Holmes
Thank you, operator, and good afternoon, everyone. Welcome to the Bionano first quarter 2024 financial results conference call. Leading the call today is Dr. Erik Holmlin, CEO of Bionano. He is joined by Gülsen Kama, CFO of Bionano. After market closed today, Bionano issued a press release announcing its financial results for the first quarter 2024. A copy of the release can be found on the Investor Relations page of the company's website.
Certain statements made during the conference call may be forward-looking statements, including statements about Bionano's revenue outlook, profitability, cash runway, cost savings initiatives and commercialization and product plans. Such statements are based on current expectations and there can be no assurances that the results contemplated in these statements will be realized. Actual results may differ materially from such statements due to a number of factors and risks, some of which are identified in Bionano's press release and Bionano's reports filed with the SEC.
These forward-looking statements are based on information available to Bionano today, May 8, 2024, and the company assumes no obligation to update statements as circumstances change. In addition, to supplement Bionano's financial results reported in accordance with the U.S. Generally Accepted Accounting Principles, or GAAP, the company reports certain non-GAAP financial measures. A description of these non-GAAP financial measures as well as the reconciliation to the nearest GAAP financial measures are included at the end of the company's earnings release issued earlier today, which has been posted on the Investor Relations page of the company's website.
These non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, should be read in conjunction with company's consolidated financial statements prepared in accordance with GAAP, have no standardized meaning prescribed by GAAP, and are not prepared under any comprehensive set of accounting rules or principles. An audio recording and webcast replay for today's conference call will also be available online on the company's Investor Relations page.